resistanceBio
VerifiedResistancebio is committed to improving the lives of cancer patients by finding cures for drug-resistant cancers.
Employees
Market cap
-
Net debt
-
Enterprise valuation
$26—38m (Dealroom.co estimates Jan 2024.)
Chesterfield Missouri (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
* | N/A | $6.4m | Debt |
| Total Funding | 000k | ||
Related Content
Recent News about resistanceBio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.